Mathew Suji Eapen

3.6k total citations · 1 hit paper
68 papers, 1.7k citations indexed

About

Mathew Suji Eapen is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Infectious Diseases. According to data from OpenAlex, Mathew Suji Eapen has authored 68 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 14 papers in Physiology and 9 papers in Infectious Diseases. Recurrent topics in Mathew Suji Eapen's work include Chronic Obstructive Pulmonary Disease (COPD) Research (32 papers), Neonatal Respiratory Health Research (14 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers). Mathew Suji Eapen is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (32 papers), Neonatal Respiratory Health Research (14 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers). Mathew Suji Eapen collaborates with scholars based in Australia, Canada and India. Mathew Suji Eapen's co-authors include Sukhwinder Singh Sohal, Stephen Myers, E. Haydn Walters, Kielan Darcy McAlinden, Pawan Sharma, Chris Ward, Philip M. Hansbro, Wenying Lu, Collin Chia and Tillie‐Louise Hackett and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Mathew Suji Eapen

66 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic targets in lung tissue remodelling and fibrosis

2021 163 citations Gang Liu, Ashleigh M. Philp et al. Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mathew Suji Eapen Australia	22	872	380	347	209	180	68	1.7k
Tianwen Lai China	25	492 0.6×	496 1.3×	317 0.9×	249 1.2×	72 0.4×	52	1.5k
Kwang Ho In South Korea	25	772 0.9×	382 1.0×	388 1.1×	265 1.3×	77 0.4×	110	1.7k
Patrick Geraghty United States	31	926 1.1×	719 1.9×	437 1.3×	337 1.6×	138 0.8×	83	2.3k
Haiyue Liu China	21	437 0.5×	826 2.2×	293 0.8×	83 0.4×	124 0.7×	41	1.5k
Sang Yeub Lee South Korea	24	849 1.0×	371 1.0×	476 1.4×	238 1.1×	47 0.3×	85	1.6k
Wojciech Piotrowski Poland	22	677 0.8×	249 0.7×	433 1.2×	125 0.6×	56 0.3×	121	1.3k
Hyung Jung Kim South Korea	23	531 0.6×	700 1.8×	278 0.8×	77 0.4×	108 0.6×	52	1.6k
Shaoxi Cai China	24	490 0.6×	712 1.9×	515 1.5×	341 1.6×	55 0.3×	110	1.9k
Richard Russell United Kingdom	17	1.2k 1.4×	399 1.1×	866 2.5×	284 1.4×	60 0.3×	64	2.2k
Kazuhisa Asai Japan	23	920 1.1×	392 1.0×	622 1.8×	264 1.3×	57 0.3×	120	1.8k

Countries citing papers authored by Mathew Suji Eapen

Since Specialization

Citations

This map shows the geographic impact of Mathew Suji Eapen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathew Suji Eapen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathew Suji Eapen more than expected).

Fields of papers citing papers by Mathew Suji Eapen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathew Suji Eapen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathew Suji Eapen. The network helps show where Mathew Suji Eapen may publish in the future.

Co-authorship network of co-authors of Mathew Suji Eapen

This figure shows the co-authorship network connecting the top 25 collaborators of Mathew Suji Eapen. A scholar is included among the top collaborators of Mathew Suji Eapen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathew Suji Eapen. Mathew Suji Eapen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oliveira, Leonardo Camilo de, Flávio Guimarães da Fonseca, Adriano de Paula Sabino, et al.. (2025). Antiviral effect of Bromelain combined with acetylcysteine against SARS-CoV-2 Omicron variant. Scientific Reports. 15(1). 11882–11882. 1 indexed citations

Lu, Wenying, Surajit Dey, Prem Bhattarai, et al.. (2024). Platelet Activating Factor Receptor and Intercellular Adhesion Molecule–1 Expression Increases in the Small Airway Epithelium and Parenchyma of Patients with Idiopathic Pulmonary Fibrosis: Implications for Microbial Pathogenesis. Journal of Clinical Medicine. 13(7). 2126–2126. 2 indexed citations

Gaikwad, Archana Vijay, Mathew Suji Eapen, Surajit Dey, et al.. (2024). TGF-β1, pSmad-2/3, Smad-7, and β-Catenin Are Augmented in the Pulmonary Arteries from Patients with Idiopathic Pulmonary Fibrosis (IPF): Role in Driving Endothelial-to-Mesenchymal Transition (EndMT). Journal of Clinical Medicine. 13(4). 1160–1160. 9 indexed citations

Eapen, Mathew Suji, Wenying Lu, Surajit Dey, et al.. (2024). Differential expression of mast cells in the small airways and alveolar septa of current smokers and patients with small airway disease and COPD. ERJ Open Research. 10(2). 579–2023. 4 indexed citations

Dey, Surajit, Wenying Lu, Heinrich C. Weber, et al.. (2024). Large airway wall vascularity in patients with asthma–COPD overlap: a bronchoscopy study. ERJ Open Research. 10(4). 2–2024. 3 indexed citations

Pontes, Letícia Gomes de, Olindo Assis Martins‐Filho, Flávio Guimarães da Fonseca, et al.. (2023). Taming the SARS-CoV-2-mediated proinflammatory response with BromAc®. Frontiers in Immunology. 14. 1308477–1308477. 3 indexed citations

Brake, Samuel James, Wenying Lu, Collin Chia, et al.. (2023). Transforming growth factor-β1 and SMAD signalling pathway in the small airways of smokers and patients with COPD: potential role in driving fibrotic type-2 epithelial mesenchymal transition. Frontiers in Immunology. 14. 1216506–1216506. 13 indexed citations

Gaikwad, Archana Vijay, Wenying Lu, Surajit Dey, et al.. (2023). Endothelial-to-mesenchymal transition: a precursor to pulmonary arterial remodelling in patients with idiopathic pulmonary fibrosis. ERJ Open Research. 9(2). 487–2022. 17 indexed citations

Dey, Surajit, Wenying Lu, Greg Haug, et al.. (2023). Airway inflammatory changes in the lungs of patients with asthma-COPD overlap (ACO): a bronchoscopy endobronchial biopsy study. Respiratory Research. 24(1). 221–221. 11 indexed citations

10.

Brake, Samuel James, Mathew Suji Eapen, Kielan Darcy McAlinden, et al.. (2022). SARS-CoV-2 (COVID-19) Adhesion Site Protein Upregulation in Small Airways, Type 2 Pneumocytes, and Alveolar Macrophages of Smokers and COPD &ndash; Possible Implications for Interstitial Fibrosis. Dove Medical Press (Taylor and Francis Group). 11 indexed citations

11.

Gaikwad, Archana Vijay, Wenying Lu, Surajit Dey, et al.. (2022). Vascular remodelling in idiopathic pulmonary fibrosis patients and its detrimental effect on lung physiology: potential role of endothelial-to-mesenchymal transition. ERJ Open Research. 8(1). 571–2021. 28 indexed citations

12.

Bhattarai, Prem, Wenying Lu, Archana Vijay Gaikwad, et al.. (2022). Arterial remodelling in smokers and in patients with small airway disease and COPD: implications for lung physiology and early origins of pulmonary hypertension. ERJ Open Research. 8(4). 254–2022. 18 indexed citations

13.

Ahmad, Tauseef, Mathew Suji Eapen, Ah Young Park, et al.. (2021). Anti-Inflammatory Activity of Fucoidan Extracts In Vitro. Marine Drugs. 19(12). 702–702. 83 indexed citations

14.

Liu, Gang, Ashleigh M. Philp, Tamera J. Corte, et al.. (2021). Therapeutic targets in lung tissue remodelling and fibrosis. Pharmacology & Therapeutics. 225. 107839–107839. 163 indexed citations breakdown →

15.

Asrani, Purva, Mathew Suji Eapen, Md. Imtaiyaz Hassan, & Sukhwinder Singh Sohal. (2021). Implications of the second wave of COVID-19 in India. The Lancet Respiratory Medicine. 9(9). e93–e94. 81 indexed citations

16.

Aghaei, Mahmoud, Sanaz Dastghaib, Mohamad‐Reza Aghanoori, et al.. (2020). The ER Stress/UPR Axis in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis. Life. 11(1). 1–1. 48 indexed citations

17.

Eapen, Mathew Suji, Pawan Sharma, Archana Vijay Gaikwad, et al.. (2019). <p>Epithelial–mesenchymal transition is driven by transcriptional and post transcriptional modulations in COPD: implications for disease progression and new therapeutics</p>. International Journal of COPD. Volume 14. 1603–1610. 21 indexed citations

18.

Sohal, Sukhwinder Singh, et al.. (2019). IQOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette. ERJ Open Research. 5(1). 159–2018. 91 indexed citations

19.

Eapen, Mathew Suji, et al.. (2015). Role of corticosteroids in chronic obstructive pulmonary disease (COPD). eCite Digital Repository (University of Tasmania). 3 indexed citations

20.

Arya, Ranjana, et al.. (2008). Purification of recombinant human phosphodiesterase 7A expressed in Dictyostelium discoideum. Protein Expression and Purification. 61(2). 149–154. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact